Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Flax Lignan Health is a nutraceutical company specializing in the production and distribution of high-quality flax hull lignans. The company focuses on the health benefits of Secoisolariciresinol Diglucoside (SDG), a phytoestrogen found in flaxseed hulls that supports hormonal balance, immune function, and cellular health. Their product line includes concentrated lignan powders and capsules marketed for indications such as menopausal symptom relief, breast and prostate health, and general antioxidant support. Flax Lignan Health emphasizes a proprietary cold-milling process to preserve the nutritional integrity of the lignans without the use of chemicals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Flax Lignan Health.